GB2499778A - Polymeric materials - Google Patents
Polymeric materials Download PDFInfo
- Publication number
- GB2499778A GB2499778A GB1200550.0A GB201200550A GB2499778A GB 2499778 A GB2499778 A GB 2499778A GB 201200550 A GB201200550 A GB 201200550A GB 2499778 A GB2499778 A GB 2499778A
- Authority
- GB
- United Kingdom
- Prior art keywords
- component
- less
- network
- voids
- polymeric material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000463 material Substances 0.000 title claims abstract description 153
- 238000000034 method Methods 0.000 claims abstract description 55
- 239000004696 Poly ether ether ketone Substances 0.000 claims abstract description 42
- 229920002530 polyetherether ketone Polymers 0.000 claims abstract description 42
- 239000007787 solid Substances 0.000 claims abstract description 18
- 239000011521 glass Substances 0.000 claims description 27
- 239000005313 bioactive glass Substances 0.000 claims description 17
- 239000007943 implant Substances 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 12
- 238000013270 controlled release Methods 0.000 claims description 11
- 238000002844 melting Methods 0.000 claims description 8
- 230000008018 melting Effects 0.000 claims description 8
- 229910019142 PO4 Inorganic materials 0.000 claims description 6
- 238000004090 dissolution Methods 0.000 claims description 5
- 239000011343 solid material Substances 0.000 claims description 5
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 4
- 239000010452 phosphate Substances 0.000 claims description 4
- 229920001652 poly(etherketoneketone) Polymers 0.000 claims description 4
- 229910021653 sulphate ion Inorganic materials 0.000 claims description 4
- 229910052586 apatite Inorganic materials 0.000 claims description 3
- 238000002513 implantation Methods 0.000 claims description 3
- 239000000155 melt Substances 0.000 claims description 3
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 claims description 3
- 229920001643 poly(ether ketone) Polymers 0.000 claims description 3
- 239000002241 glass-ceramic Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 abstract description 21
- 239000001506 calcium phosphate Substances 0.000 abstract description 18
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 abstract description 18
- 229910000391 tricalcium phosphate Inorganic materials 0.000 abstract description 17
- 235000019731 tricalcium phosphate Nutrition 0.000 abstract description 17
- 229940078499 tricalcium phosphate Drugs 0.000 abstract description 17
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract description 14
- 239000005312 bioglass Substances 0.000 abstract description 7
- 239000000203 mixture Substances 0.000 abstract description 7
- 239000011780 sodium chloride Substances 0.000 abstract description 7
- 238000012856 packing Methods 0.000 abstract description 4
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 15
- KKCBUQHMOMHUOY-UHFFFAOYSA-N Na2O Inorganic materials [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 11
- 239000000843 powder Substances 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 9
- 229910001948 sodium oxide Inorganic materials 0.000 description 9
- 239000002904 solvent Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000377 silicon dioxide Substances 0.000 description 7
- 235000012239 silicon dioxide Nutrition 0.000 description 7
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 6
- 239000000945 filler Substances 0.000 description 6
- 125000004430 oxygen atom Chemical group O* 0.000 description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 6
- 239000003607 modifier Substances 0.000 description 5
- 235000021317 phosphate Nutrition 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 229920001519 homopolymer Polymers 0.000 description 4
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 3
- 230000000975 bioactive effect Effects 0.000 description 3
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 229910010293 ceramic material Inorganic materials 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- JKWMSGQKBLHBQQ-UHFFFAOYSA-N diboron trioxide Chemical compound O=BOB=O JKWMSGQKBLHBQQ-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000003754 machining Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 229920005604 random copolymer Polymers 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000004736 wide-angle X-ray diffraction Methods 0.000 description 2
- 229920004731 VICTREX® PEEK 450PF Polymers 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000287 alkaline earth metal oxide Inorganic materials 0.000 description 1
- -1 alkaline earth metal salt Chemical class 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000001175 calcium sulphate Substances 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 210000001145 finger joint Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229910000311 lanthanide oxide Inorganic materials 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 239000012768 molten material Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229910052585 phosphate mineral Inorganic materials 0.000 description 1
- 229920006260 polyaryletherketone Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- UONOETXJSWQNOL-UHFFFAOYSA-N tungsten carbide Chemical compound [W+]#[C-] UONOETXJSWQNOL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/26—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a solid phase from a macromolecular composition or article, e.g. leaching out
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/24—Materials or treatment for tissue regeneration for joint reconstruction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/38—Materials or treatment for tissue regeneration for reconstruction of the spine, vertebrae or intervertebral discs
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2201/00—Foams characterised by the foaming process
- C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
- C08J2201/044—Elimination of an inorganic solid phase
- C08J2201/0444—Salts
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2201/00—Foams characterised by the foaming process
- C08J2201/04—Foams characterised by the foaming process characterised by the elimination of a liquid or solid component, e.g. precipitation, leaching out, evaporation
- C08J2201/044—Elimination of an inorganic solid phase
- C08J2201/0444—Salts
- C08J2201/0446—Elimination of NaCl only
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2207/00—Foams characterised by their intended use
- C08J2207/10—Medical applications, e.g. biocompatible scaffolds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2371/00—Characterised by the use of polyethers obtained by reactions forming an ether link in the main chain; Derivatives of such polymers
- C08J2371/08—Polyethers derived from hydroxy compounds or from their metallic derivatives
- C08J2371/10—Polyethers derived from hydroxy compounds or from their metallic derivatives from phenols
- C08J2371/12—Polyphenylene oxides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Dispersion Chemistry (AREA)
- Prostheses (AREA)
Abstract
An upright column is packed with particles of a first material so the particles touch one another and a network of voids is defined between the particles. The network will be substantially continuous. A second material is then introduced into the column so the second material penetrates the network and fills the voids. The mixture of first and second materials is then consolidated using heat to melt the first or second material, whilst the other one of the first or second material remains in a solid state and acts as a space holder. Thereafter, the material which acts as the space holder may be removed thereby to leave a substantially continuous porous network defined by the material which was melted. It is found that, by use of the method, a substantially continuous network of the material which is melted can be formed and that the other material can readily be removed and/or is more easily removed compared to if a mixture of first and second materials was formed prior to packing in a column or mould. In embodiments, the second material is PEEK while the first removable material can be sodium chloride, tricalcium phosphate, bioglass.
Description
1
POLYMERIC MATERIALS
This invention relates to a polymeric material and particularly, although not exclusively, relates to a material comprising a polymeric material and a filler, for example a fugitive or resorbable 5 material, wherein the filler may be removable in order to define a porous structure defined by the polymeric material. In preferred embodiments, the material defines an osseoconductive polymeric material and/or is suitable for medical use such as for making medical implants or parts thereof. Preferred embodiments relate to materials comprising polyaryletherketones, for example polyetheretherketone (PEEK).
10
It is well known to make porous medical implants and there are numerous prior art proposals. For example, W02007/051307 discloses porous medical implants made from polyetheretherketone and salt (e.g. sodium chloride) in a process wherein the ingredients are placed in a mould cavity, compressed and heated to melt the polyetheretherketone but not the 15 salt and form a moulded part. After subsequent cooling to solidify the mixture, the moulded material is placed in a water bath at 100°C to dissolve the salt from the moulded part and define a porous moulded part.
US5969020 discloses microporous polymeric foams and microtextured surfaces suitable for 20 medical applications. In preparing the foams, an organic crystalline polymer is melted and combined with a selected solid crystalline fugitive compound to produce a substantially isotropic solution. The solution is cooled under controlled conditions, which foster solid-solid phase separation by the simultaneous crystallization of the fugitive compound and the polymer, to produce a foam precursor containing the solidified fugitive compound dispersed 25 through a matrix of the organic polymer. Crystals of fugitive compound are then removed by solvent extraction and/or sublimation, or like process to produce microcellular foams having a continuous, open-cell structure.
In such porous materials, the fugitive material must be completely removed in an appropriate 30 process to ensure the porous material is not contaminated with any potentially toxic agents prior to implantation. Complete removal can be difficult and, accordingly, there is a risk that levels of fugitive material may remain even after (attempted) removal.
In porous materials for medical implants, it is desirable to define a substantially fully 35 interconnected network of voids, firstly to facilitate complete removal of a fugitive materials used in the preparation of the porous material and, secondly, to define a highly osseoconductive material.
It is an object of the present invention to address the above-described problems.
2
According to a first aspect of the invention, there is provided a method of making a material, the method comprising:
(a) selecting a receptacle which contains a mass which defines a network of voids, 5 said mass comprising a first component;
(b) introducing a second component into the receptacle so that the second component percolates the network and enters the voids, thereby to produce a material which comprises said first and second components.
10
One of said first or second components may comprise, preferably consist essentially of, a polymeric material. Thus, said material made in the method preferably comprises a polymeric material.
15 Said polymeric material preferably comprises a bio-compatible polymeric material. Said polymeric material preferably comprises a thermoplastic polymer.
Said polymeric material may have a Notched Izod Impact Strength (specimen 80mm x 10mm x 4mm with a cut 0.25mm notch (Type A), tested at 23°C, in accordance with IS0180) of at least 20 4KJm"2, preferably at least 5KJm"2, more preferably at least 6KJm"2. Said Notched Izod Impact Strength, measured as aforesaid, may be less than 10KJm"2, suitably less than 8KJm"2.
The Notched Izod Impact Strength, measured as aforesaid, may be at least 3KJm"2, suitably at least 4KJm"2, preferably at least 5KJm"2. Said impact strength may be less than 50 KJm"2, 25 suitably less than 30KJm"2.
Said polymeric material suitably has a melt viscosity (MV) of at least 0.06 kNsm"2, preferably has a MV of at least 0.09 kNsm"2, more preferably at least 0.12 kNsm"2, especially at least 0.15 kNsm"2.
30
MV is suitably measured using capillary rheometry operating at 400°C at a shear rate of 1000s"1 using a tungsten carbide die, 0.5mmx3.175mm.
Said polymeric material may have a MV of less than 1.00 kNsm"2, preferably less than 0.5 35 kNsm"2.
Said polymeric material may have a MV in the range 0.09 to 0.5 kNsm"2, preferably in the range 0.14 to 0.5 kNsm"2, more preferably in the range 0.14 to 0.5 kNsm"2.
3
Said polymeric material may have a tensile strength, measured in accordance with IS0527 (specimen type 1b) tested at 23°C at a rate of 50mm/minute of at least 20 MPa, preferably at least 60 MPa, more preferably at least 80 MPa. The tensile strength is preferably in the range 80-110 MPa, more preferably in the range 80-100 MPa.
5
Said polymeric material may have a flexural strength, measured in accordance with IS0178 (80mm x 10mm x 4mm specimen, tested in three-point-bend at 23°C at a rate of 2mm/minute) of at least 50 MPa, preferably at least 100 MPa, more preferably at least 145 MPa. The flexural strength is preferably in the range 145-180MPa, more preferably in the range 145-164 10 MPa.
Said polymeric material may have a flexural modulus, measured in accordance with IS0178 (80mm x 10mm x 4mm specimen, tested in three-point-bend at 23°C at a rate of 2mm/minute) of at least 1 GPa, suitably at least 2 GPa, preferably at least 3 GPa, more preferably at least 15 3.5 GPa. The flexural modulus is preferably in the range 3.5-4.5 GPa, more preferably in the range 3.5-4.1 GPa.
Said polymeric material may be amorphous or semi-crystalline. It is preferably crystallisable. It is preferably semi-crystalline.
20
The level and extent of crystallinity in a polymer is preferably measured by wide angle X-ray diffraction (also referred to as Wide Angle X-ray Scattering or WAXS), for example as described by Blundell and Osborn (Polymer 24, 953, 1983). Alternatively, crystallinity may be assessed by Differential Scanning Calorimetry (DSC).
25
The level of crystallinity of said polymeric material may be at least 1%, suitably at least 3%, preferably at least 5% and more preferably at least 10%. In especially preferred embodiments, the crystallinity may be greater than 25%. It may be less than 50% or less than 40%.
30 The main peak of the melting endotherm (Tm) of said polymeric material (if crystalline) may be at least 300°C.
Said polymeric material may include a repeat unit of general formula
35
4
or a repeat unit of general formula
■E>WO}4-E'4^
OttS02T O
V
wherein A, B, C and D independently represent 0 or 1, provided at least one of A or B represents 1 and at least one of C or D represents 1, E and E' independently represent an oxygen or a sulphur atom or a direct link, G represents an oxygen or sulphur atom, a direct link or a -O-Ph-O-moiety where Ph represents a phenyl group, m, r, s, t, v, w, and z represent zero or 1 and Ar is selected from one of the following moieties (i) to (v) which is bonded via one or more of its phenyl moieties to adjacent moieties
10
CH,
(i)
\ /HTA /
CH,
(ii)
(iv)
-O-
\ /
(v)
V /
5
Preferably A and B represent 1. Preferably C and D represent 1.
5 Unless otherwise stated in this specification, a phenyl moiety has 1,4-, linkages to moieties to which it is bonded.
Said polymeric material may be a homopolymer which includes a repeat unit of IV or V or may be a random or block copolymer of at least two different units of IV and/or V.
10
As an alternative to a polymeric material comprising units IV and/or V discussed above, said polymeric material may include a repeat unit of general formula or a homopolymer having a repeat unit of general formula
15
wherein A, B, C, and D independently represent 0 or 1, provided at least one of A or B represents 1 and at least one of C or D represents 1, and E, E', G, Ar, m, r, s, t, v, w and z are as described in any statement herein. Preferably, in IV* and V*, A and B represent 1; and C and D represent 1.
20 Said polymeric material may be a homopolymer which includes a repeat unit of IV* or V* or a random or block copolymer of at least two different units of IV* and/or V*.
Preferably, said polymeric material is a homopolymer having a repeat unit of general formula IV.
25 Preferably Ar is selected from the following moieties (vi) to (x)
(vi)
CH,
\ / I \ /
CH,
(vii)
-CO—A- —CO-
\ //
(viii) —\ 7—00—rt
(ix)
-o-
\ /rn /
(X)
\ /
5 In (vii), the middle phenyl may be 1,4- or 1,3-substituted. It is preferably 1,4-substituted.
Suitable moieties Ar are moieties (ii), (iii), (iv) and (v) and, of these, moieties, (ii), (iii) and (v) are preferred. Other preferred moieties Ar are moieties (vii), (viii), (ix) and (x) and, of these, moieties (vii), (viii) and (x) are especially preferred.
10
An especially preferred class of polymeric materials are polymers (or copolymers) which consist essentially of phenyl moieties in conjunction with ketone and/or ether moieties. That is, in the preferred class, the polymer material does not include repeat units which include -S-, -S02- or aromatic groups other than phenyl. Preferred bio-compatible polymeric materials of the type 15 described include:
7
(a) a polymer consisting essentially of units of formula IV wherein Ar represents moiety (v), E and E' represent oxygen atoms, m represents 0, w represents 1, G represents a direct link, s represents 0, and A and B represent 1 (i.e. polyetheretherketone).
5
(b) a polymer consisting essentially of units of formula IV wherein E represents an oxygen atom, E' represents a direct link, Ar represents a moiety of structure (ii), m represents 0, A represents 1, B represents 0 (i.e. polyetherketone);
10 (c) a polymer consisting essentially of units of formula IV wherein E represents an oxygen atom, Ar represents moiety (ii), m represents 0, E' represents a direct link, A represents 1, B represents 0, (i.e. polyetherketoneketone).
(d) a polymer consisting essentially of units of formula IV wherein Ar represents 15 moiety (ii), E and E' represent oxygen atoms, G represents a direct link, m represents 0, w represents 1, r represents 0, s represents 1 and A and B represent 1. (i.e. polyetherketoneetherketoneketone).
(e) a polymer consisting essentially of units of formula IV, wherein Ar represents 20 moiety (v), E and E' represents oxygen atoms, G represents a direct link, m represents 0, w represents 0, s, r, A and B represent 1 (i.e. polyetheretherketoneketone).
(f) a polymer comprising units of formula IV, wherein Ar represents moiety (v), E and 25 E' represent oxygen atoms, m represents 1, w represents 1, A represents 1, B
represents 1, r and s represent 0 and G represents a direct link (i.e. polyether-diphenyl-ether-phenyl-ketone-phenyl-).
Said polymeric material may consist essentially of one of units (a) to (f) defined above. 30 Alternatively, said polymeric material may comprise a copolymer comprising at least two units selected from (a) to (f) defined above. Preferred copolymers include units (a). For example, a copolymer may comprise units (a) and (f); or may comprise units (a) and (e).
Said polymeric material preferably comprises, more preferably consists essentially of, a repeat 35 unit of formula (XX)
x ' L > ' J ti N ' L x ' Jw1 L N ' J v1
8
where t1, and w1 independently represent 0 or 1 and v1 represents 0, 1 or 2. Preferred polymeric materials have a said repeat unit wherein t1 = 1, v1=0 and w1=0; t1 =0, v1=0 and w1=0; t1=0, w1=1, v1=2; or t1=0, v1=1 and w1=0. More preferred have t1 = 1, v1=0 and w1=0; or t1=0, v1=0 and w1=0. The most preferred has t1=1, v1=0 and w1=0.
5
In preferred embodiments, said polymeric material is selected from polyetheretherketone, polyetherketone, polyetherketoneetherketoneketone and polyetherketoneketone. In a more preferred embodiment, said polymeric material is selected from polyetherketone and polyetheretherketone. In an especially preferred embodiment, said polymeric material is 10 polyetheretherketone.
One of said first or second components preferably consists essentially of said polymeric material and, more preferably, consists essentially of polyetheretherketone.
15 The other one of said first or second components preferably comprises a fugitive or resorbable material. Said material preferably has a higher melting point (suitably by at least 50°C, preferably at least 100°C, more preferably by at least 200°C, especially by at least 300°C) than the polymeric material with which it is associated in the method.
20 Said fugitive or resorbable material may have a melting point of at least 450°C, preferably at least 500°C, more preferably at least 600°C, especially at least 700°C.
The other one of said first or second components may be selected from a salt, apatite, phosphate, sulphate, bioactive glass, controlled release glass and a glass ceramic. Where 25 said component is a salt, it may comprise a water soluble salt. It may comprise an alkaline or alkaline earth metal salt, for example a halide, especially sodium chloride.
When said component is an apatite, it may comprise a hydroxyapatite.
30 Where said component comprises a phosphate, the phosphate may be resorbable. It may comprise a phosphate mineral. Preferred phosphates include apatites (especially hydroxyapatites) and calcium-containing phosphates, for example a tri-calcium phosphate.
A sulphate may be a calcium-containing sulphate, for example calcium sulphate.
35
Preferred bioactive glasses include greater than 50 mole% of Si02, less than 10 mole% CaO and less than 35 mole% of Na20. They are preferably resorbable.
9
An especially preferred bioactive glass includes less than 20 mole% sodium oxide and/or is water soluble.
Said bioactive glass suitably includes a glass former and a glass modifier. A glass former may 5 be selected from silicon dioxide, phosphorous pentoxide or boron trioxide. Said glass former preferably comprises silicon dioxide or phosphorous pentoxide. Said bioactive glass suitably includes 85mole% or less, preferably 75mole% or less of a said glass former. A glass modifier may be an oxide or carbonate, for example a metal oxide or carbonate or a lanthanide oxide or carbonate. A metal of said oxide or carbonate may be an alkali or alkaline earth metal. Said 10 bioactive glass preferably includes a glass modifier selected from Li20, Na20, K20, MgO, ZnO and CaO. The sum of the amount of glass formers and glass modifiers in said bioactive glass may be at least 80mole%, preferably at least 90mole%, more preferably at least 95mole%. Said bioactive glass may include other compounds in addition to said glass former and glass modifier. Less than 20mole%, preferably less than 10mole%, more preferably less than 15 5mole% of other compounds may be included.
A bioactive glass as described is suitably able to elicit a reaction when implanted in a human body. For example, being "bioactive" may imply chemical formation of a calcium phosphate layer (amorphous, partially crystalline or crystalline) via ion exchange between surrounding 20 fluid in vitro and the ceramic material. In vitro assessment of whether a said ceramic material is bioactive may be undertaken as described by Kokubo at Biomaterials (2006) 27:2907-2915
Said bioactive glass may include less than 15mole% sodium oxide, suitably less than 13mole% sodium oxide, preferably less than 10mole% sodium oxide, more preferably less 25 than 7mole% sodium oxide, especially less than 3mole% sodium oxide. In some cases, said bioactive glass may include less than 1mole% sodium oxide, preferably 0mole% of sodium oxide.
The total amount of alkali metal oxide in said bioactive glass may be less than 15mole%, 30 suitably less than 13mole%, preferably less than 10mole%, more preferably less than 7mole%, especially less than 3mole%. In some cases, the total amount may be less than 1mole% and is preferably 0mole%.
A bioactive glass as described may include silicon dioxide as a glass former. It may include at 35 least 10mole%, suitably at least 20mole%, preferably at least 30mole%, more preferably at least 40mole% of silicon dioxide. The amount of silicon dioxide may be less than 70mole%, suitably less than 60mole%.
10
A said bioactive glass which includes a high level of silicon dioxide may be insoluble in water or have low solubility.
Properties of bio-active glasses may be dependent on the network connectivity, see Journal of 5 Materials Science: Material in Medicine 10 (1999) 697-701 (Wallace) and Journal of Materials Science Letters 15 (1996) 1122-1125 (Hill). Said bio-active glass may have a network connectivity of 2 or greater, preferably greater than 2.1. The network connectivity may be less than 3.2, preferably less than 2.5. The cross-link density as discussed in the aforementioned Hill paper may be greater than -0.10, preferably greater than 0. The cross-link density may be 10 less than 0.8.
Controlled release glasses could also be bioactive but need not be. Controlled release glasses are preferably biocompatible and/or biologically inert. A said controlled release glass suitably includes less than 20mole%, preferably less than 10mole%, more preferably less than 15 5mole%, especially less than 1mole% of silicon dioxide. A said controlled release glass may include phosphorous pentoxide as a glass former. It may include at least 10mole%, preferably at least 20mole%, more preferably at least 25mole%, especially at least 30mole% of phosphorous pentoxide. The amount of phosphorous pentoxide may be less than 85mole% or less than 60mole%. A said controlled release glass suitably includes less than 15mole%, 20 suitably less than 13mole%, preferably less than 10mole%, more preferably less than 7mole%, especially less than 5mole% of sodium oxide. The total amount of alkali metal oxide in said controlled release glass is suitably less than 15mole%, suitably less than 13mole%, preferably less than 10mole%, more preferably less than 7mole%, especially less than 5mole% of alkali metal oxide.
25
Said controlled release glass may include an alkaline earth metal oxide or carbonate or oxide or carbonate of a lanthanide. The total amount of such oxides or carbonates in said glass may be less than 80mole%, preferably less than 75mole%, more preferably less than 70mole%, especially less than 60mole%. The total amount of such oxides or carbonates in said glass 30 may be at least 5mole%, preferably at least 15mole%, more preferably at least 25mole%. The total amount of such oxides or carbonates in said glass may be up to 40mole%.
Said controlled release glass is preferably completely soluble in water at 38°C. On dissolution (in isolation), said controlled release glass suitably has a pH of less than 7, suitably less than 35 6.8, preferably less than 6.5, more preferably less than 6.
Said mass which defines a network of voids referred to in step (a) may comprise particles (e.g. of a powder) which contact one another within the receptacle, wherein voids are defined between the particles. Prior to step (b), the particles may contact but may not be adhered or
11
fused together. In an alternative embodiment, the mass selected in step (a) may comprise a scaffold which may be defined by members, for example filaments, of said first component. Said members may overlie one another for example to define a grid-like scaffold or lattice, wherein gaps are defined between the members. In this case, therefore, the mass selected in 5 step (a) may comprise a pre-formed structure in which openings or voids are defined.
The voids defined in the mass selected in step (a) may be such that particles having a maximum dimension of less than 300[jnri or less than 200[jnri or less than 100[jnri are able to pass through.
10
Said first component may have a D50 of 100[jnri to 1000^m, suitably 200[jnri to 800[jnri, preferably 300[jnri to 700jjm, especially 400[jm to 600[jnri.
Said second component may have a D50 less than that of said first component. The D50 may 15 be less than 200[jnri, less than 150[jnri or less than 100^m.
The ratio of the D50 of the first component divided by the D50 of the second component may be at least 3, at least 4 or at least 5; it may be less than 10, 8 or 6.
20 The mass in said receptacle selected in step (a) preferably includes less than 5wt%, less than 4wt%, less than 3wt%, less than 2wt%, less than 1wt% of a solvent (e.g. water) or other liquid, measured at the temperature of the mass just prior to introduction of said second component in step (b).
25 In step (b), an inputted material which comprises said second component is introduced into the receptacle. In one embodiment, the inputted material may comprise said second component dispersed in a solvent; in another embodiment, said inputted material may consist essentially of a mass of solid material which suitably includes at least 90wt%, preferably at least 95wt%, more preferably at least 99wt% of said second component. Said inputted material preferably 30 includes particles suitably of said second component, which are suitably sized to pass through said network of voids defined by said mass comprising said first component.
Said inputted material is suitably introduced into the mass so that the network of voids is substantially filled with solid material which comprises, preferably consists essentially of, said 35 second component.
Where the method involves the inputted material comprising a solvent, the receptacle may include means (e.g. a frit at a lower end thereof) for allowing the solvent to pass out of the receptacle whilst leaving the second component in the receptacle within the network of voids.
12
When said inputted material consists essentially of solid material, means may be provided for preventing said second components passing through and out of the receptacle.
After step (b), less than 15%, less than 10% or less than 5% of the volume of said mass of 5 materials in the receptacle comprises voids. Thus, preferably at least 85%, at least 90% or at least 95% of the volume of the material in the receptacle is defined by solid material.
In step (b), the inputted material may be introduced in a molten state and/or under pressure. Alternatively, the inputted material may be introduced towards an upper end of the receptacle 10 and vibratory movement applied to the receptacle to encourage the inputted material to move through the mass, for example under gravity.
In one embodiment, the first component may comprise a said fugitive and/or resorbable material as described herein and said second component preferably comprises, or consists 15 essentially, of a said polymeric material. Advantageously, by providing the fugitive and/or resorbable material in the receptacle selected in step (a), it may be easier to control porosity and/or interconnectivity in the material produced. In another embodiment, where the first component comprises said polymeric material, materials may be more easily made with improved strength.
20
The method may include heating one of said first or second components above its melting point. Preferably, the other one of said components is heated to a temperature below its melting point. It is preferred that the polymeric material used in the method is heated above its melting point. In one embodiment, said method includes a step (c), after step (b), wherein 25 said first and second components are heated so that the polymeric material melts whilst the other component remains in a solid state. In another embodiment, the second component may be introduced into the receptacle in step (b) with the second component in a molten state. It may be forced under pressure into voids defined by the first component.
30 The method preferably includes the step of allowing the receptacle to cool (or actively cooling it) so that the polymeric material solidifies.
After step (b), said material suitably includes at least 20wt%, preferably at least 30wt%, more preferably at least 40wt%, especially at least 45wt% of said first component. Said material 35 may include less than 70wt%, or less than 60wt%, of said first component.
After step (b), said material suitably includes at least 20wt%, preferably at least 30wt%, more preferably at least 40wt%, especially at least 45wt% of said second component. Said material may include less than 70wt%, or less than 60wt% of said second component.
13
After step (b), said material suitably includes 40-60wt% of said first component and 40-60wt% of said second component.
5 The method may include a step (a*), prior to step (a), which comprises introducing said first component into said receptacle so that it defines said network of voids. Said first component may be in a solid form immediately prior to its introduction into said receptacle. The method may include applying vibratory movement to the receptacle to facilitate packing of said first component in the receptacle.
10
The method may include a step after step (b) of removal of the material comprising the first and second components from the receptacle. The material is preferably removed in the form of a single solid mass which comprises the first and second components. Said first and second components define a substantially homogenous mass. Suitable the first and second 15 components are in solid form and are preferably substantially immovably arranged within the mass.
The method may include a further step of changing the shape or size of the material removed after step (b), for example by machining, in order to form the material into a part for 20 subsequent use.
The method may include a dissolution step after step (b) which comprises removing, suitably by dissolution using a solvent, fugitive or resorbable (preferably fugitive) material from said material. The solvent used may be aqueous and suitably includes greater than 80wt%, greater 25 than 90wt% or greater than 95wt% water. Preferably, substantially all fugitive or resorbable material is removed thereby to leave porous polymeric material.
The material removed from the receptacle may be used after optional shaping or sizing (e.g. machining) in non-medical or medical applications. It may define a part or the whole of a 30 device which may be incorporated into or associated with a human body. Thus, it may suitably be a part of or the whole of a medical implant. The medical implant may be arranged to replace or supplement soft or hard tissue. It may replace or supplement bone. It may be used in addressing trauma injury or craniomaxillofacial injury. It may be used in joint replacement, for example as part of a hip or finger joint replacement; or in spinal surgery.
35
In an especially preferred embodiment, said material made in the method includes at least 40%wt, preferably at least 45wt%, more preferably at least 50wt% of polyetheretherketone. When material has been subjected to a dissolution step, said material may comprise at least 95wt% or preferably consist essentially of porous polyetheretherketone.
14
Said receptacle may comprise a mould, for example, defining at least in part, a medical implant or part thereof. The mould preferably includes an internal wall or walls which contact(s) the first component (and preferably to some extent the second component) in the method.
5 Preferably, the material made in the method is disengaged from the wall or walls at the end of the method, thereby to separate the material made in the method from the mould. The mould preferably includes a substantially smooth wall or walls which the material abuts in the method, prior to removal from the mould. The mould may be any desired shape and/or may be designed to define at least part of the shape of a medical implant or part thereof that may be 10 made in the method.
In one embodiment, the first component (e.g. a fugitive or resorbable material, especially sodium chloride) may comprise substantially spherical particles which are used with particles of a said second component (which preferably comprises polyetheretherketone). The 15 spherical filler (e.g. of sodium chloride) may be made as described in Journal of Alloys and Compounds 499 (2010) 43-47 or as described in Biomaterials 25 (2004) 4955-4962.
In one embodiment, a mould used in the method may be modified by inclusion of a grid (or the like) associated with a lower internal wall of the mould. The grid is intended to provide a 20 means whereby grains (e.g. spherical grains) of first component can be spaced from other grains in the same row, so that the first component is less tightly packed in the mould. The first component (e.g. comprising spherical grains of sodium chloride) may be sintered to set the shape of the filler material and subsequently polymeric material may be introduced into the sintered first component to define a mixture. After heating to melt the polymeric material, the 25 first component may be dissolved to leave a structure defined by the polymeric material which is more open.
According to a second aspect of the invention, there is provided a material made in a method according to the first aspect.
30
According to a third aspect, there is provided a method of making a medical implant or part of a medical implant for implantation in a human body, the method using a material made as described according to the first aspect.
35 In one embodiment, the method may include the step of removing the fugitive or resorbable material in order to define the medical implant or part thereof. In another embodiment, a medical implant or part thereof which incorporates the fugitive or resorbable material may be used as medical implant. In this case, the fugitive or resorbable material may be arranged to leach out of the medical implant or part thereof in vivo.
15
The invention extends to a medical implant or part thereof for use in the human body.
Any feature of any aspect of any invention or embodiment described herein may be combined 5 with any feature of any aspect of any invention or embodiment described herein mutatis mutandis.
Specific embodiments of the invention will now be described, by way of example.
10 The following materials are referred to hereinafter
PEEK micropellets - refer to cylindrical particles of PEEK having a diameter of approximately 600[jnri and 600[jnri in length. The pellets may be based on PEEK Optima LT1 or LT2 (MV 0.45kNsm"2 and 0.38kNsm"2).
15
Tricalcium phosphate particles were obtained from PlasmaBioTal UK.
In general terms, an upright column is packed with particles of a first material so the particles touch one another and a network of voids is defined between the particles. The network will be 20 substantially continuous. A second material is then introduced into the column so the second material penetrates the network and fills the voids. The mixture of first and second materials is then consolidated using heat to melt the first or second material, whilst the other one of the first or second material remains in a solid state and acts as a space holder. Thereafter, the material which acts as the space holder may be removed thereby to leave a substantially 25 continuous porous network defined by the material which was melted. It is found that, by use of the method, a substantially continuous network of the material which is melted can be formed and that the other material can readily be removed and/or is more easily removed compared to if a mixture of first and second materials was formed prior to packing in a column or mould.
30
The following examples describe preferred embodiments:
Example 1
An upright column of 30mm diameter was packed with spherical sodium chloride particles, 35 made by stirring solid salt particles in hot oil at 80°C. The column was closed at both ends by porous frits, with pores size less than 100[jnri. Alternatively, the lower end could be closed by a solid body instead of the frit. 70[jm PEEK powder (Victrex PEEK 450 PF) was placed on top of the upper frit and vibrated (using an AutoTap from QuantaChrome UK) so that the PEEK powder sedimented down into and through the salt bed. The column was then placed in an
16
oven and heated at 400°C for 45 minutes to melt the polymer and produce a network of interconnected polymer with salt particles in between. Alternative methods of aiding packing of the bed include sintering the bed materials at a temperature near the melting point or by cold compressing the packed bed (e.g. at 250 Newtons).
5
Example 2
The procedure of Example 1 was followed except that the 70[jm PEEK powder was suspended in ethanol, introduced into the salt bed and allowed to pass into the bed so that the PEEK powder sedimented down throughout the salt bed. The column was heated as 10 described in Example 1.
Example 3
A column of 30mm diameter was packed with PEEK micro pellets. The bottom of the column was closed by a solid body. Tri calcium phosphate (TCP) powder of 20[jm was placed on top 15 of the PEEK bed and vibrated so that the TCP powder sedimented down through the PEEK bed and backed up, filling the interstitial spaces between the PEEK. The column was heated as described in Example 1.
Example 4
20 A column of 30mm diameter was packed with spherical soluble bioglass particles obtained from Mo-Sci. The bottom of the column was closed by a solid body. PEEK powder of 70[jm was placed on top of the bioglass bed and vibrated so that the PEEK powder sedimented down through the bioglass bed, filling the spaces between the bioglass particles. The column materials were then compressed to further pack the mix. The column was then placed in an 25 oven and heated at 400°C for 45 minutes to melt the polymer. The PEEK/bioglass mass was removed from the column and leached in a boiling water solution for 4 hours to dissolve the bioglass and produce a porous rod.
Example 5
30 A column of 30mm diameter was packed with spherical 300[jnri Tricalcium phosphate (TCP) particles. The bottom of the column was closed by a solid body. PEEK powder of 70[jm diameter was placed on top of the TCP bed and vibrated so that the PEEK powder sedimented down through the TCP bed until reaching the bottom. The PEEK then backed up in the column, filling the spaces in between the TCP spheres. The column was then placed in an 35 oven and heated at 400°C for 45 minutes to melt the polymer. The compound was removed from the column and machined to small disk shapes. These could then be used still filled with TCP or the TCP could be removed with solvent to leave a porous PEEK structure.
Example 6
17
A column of 30mm diameter was packed with spherical 300[jnri Tricalcium phosphate particles. The bottom of the column was closed by a solid body. The column was connected to a heater element and ram extruder. Molten PEEK was then forced through the bed under pressure so that the molten material flowed down through the spaces in between the TCP spheres. It was found that lower viscosity PEEK aided the flow through the bed. The PEEK was allowed to flow out of the base of the column through a 200[jnri orifice. After cooling, the compound was removed from the column and machined to small disk shapes. These could then be used, still filled with TCP or the TCP could be removed with a solvent to leave a porous PEEK structure.
In alternative embodiments, a construct may be made having solid and filled areas. For example, a solid (unfilled) PEEK layer may be formed in a column and a PEEK/filler layer formed on the top of the PEEK layer. The filler may be removed to provide a construct comprising a solid PEEK layer and a porous PEEK layer.
In another alternative, instead of the column, a mould may be used which is arranged so that sedimentation of a second material can only take place in selected channels. A rod (or the like) may thereby be formed which may include a central core with an outer filled (or porous) cylindrical region around the core; or a rod (or the like) may be formed with an inner filled (or porous) central core with an outer solid PEEK cylindrical region.
The invention is not restricted to the details of the foregoing embodiment(s). The invention extends to any novel one, or any novel combination, of the features disclosed in this specification (including any accompanying claims, abstract and drawings), or to any novel one, or any novel combination, of the steps of any method or process so disclosed.
18
CM O CM
Claims (1)
1. A method of making a material, the method comprising:
5 (a) selecting a receptacle which contains a mass which defines a network of voids,
said mass comprising a first component;
(b) introducing a second component into the receptacle so that the second component percolates the network and enters the voids, thereby to produce a material which 10 comprises said first and second components.
2. A method according to claim 1, wherein one of said first or second components comprises a polymeric material.
15 3. A method according to claim 1 or claim 2, wherein said polymeric material comprises a repeat unit of formula (XX)
20
\ /
\ /
-co
\ /
\ /
w1
■CO
\ /
v1
where t1, and w1 independently represent 0 or 1 and v1 represents 0, 1 or 2.
4. A method according to claim 2 or claim 3, wherein said polymeric material is selected from polyetheretherketone, polyetherketone, polyetherketoneetherketoneketone and polyetherketoneketone.
25 5. A method according to any of claims 2 to 4, wherein one of said first or second components consists essentially of said polymeric material.
30
6. A method according to any of claims 2 to 5, wherein the other one of said first or second components comprises a fugitive or resorbable material.
7. A method according to claim 6, wherein said fugitive or resorbable material has a melting point of at least 450°C.
35
8. A method according to any of claims 2 to 7, wherein the other one of said first or second components is selected from a salt, apatite, phosphate, sulphate, bioactive glass, controlled release glass and a glass ceramic.
19
9. A method according to any preceding claim, wherein said first component has a D50 of lOOfjm to lOOOfjm; and said second component has a D50 less than that of said first component.
5 10. A method according to any preceding claim, wherein the ratio of the D50 of the first component divided by the D50 of the second component is at least 3.
11. A method according to any preceding claim, wherein in step (b), an inputted material which comprises said second component is introduced into the receptacle.
0
12. A method according to claim 11, wherein said inputted material is introduced into the mass so that the network of voids is substantially filled with solid material which comprises said second component.
15 13. A method according to claim 11 or claim 12, wherein in step (b), the inputted material is introduced in a molten state and/or under pressure.
CM
14. A method according to any preceding claim, wherein the first component comprises a ^ fugitive and/or resorbable material and said second component comprises a polymeric
20 material.
CM
25
15. A method according to any preceding claim, wherein said method includes a step (c), after step (b), wherein said first and second components are heated so that the polymeric material melts whilst the other component remains in a solid state.
16. A method according to any preceding claim, the method including a step (a*), prior to step (a), which comprises introducing said first component into said receptacle so that it defines said network of voids.
30 17. A method according to any preceding claim, the method including a dissolution step after step (b) which comprises removing fugitive or resorbable material from said material.
18. A material made in a method according to any preceding claim.
35 19. A method of making a medical implant or part of a medical implant for implantation in a human body, the method using a material made as described in any of claims 1 to 18.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1117633.6A GB201117633D0 (en) | 2011-10-12 | 2011-10-12 | Polymeric materials |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB201200550D0 GB201200550D0 (en) | 2012-02-29 |
| GB2499778A true GB2499778A (en) | 2013-09-04 |
Family
ID=45091946
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1117633.6A Ceased GB201117633D0 (en) | 2011-10-12 | 2011-10-12 | Polymeric materials |
| GB1200550.0A Withdrawn GB2499778A (en) | 2011-10-12 | 2012-01-13 | Polymeric materials |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1117633.6A Ceased GB201117633D0 (en) | 2011-10-12 | 2011-10-12 | Polymeric materials |
Country Status (1)
| Country | Link |
|---|---|
| GB (2) | GB201117633D0 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2536388A (en) * | 2016-06-29 | 2016-09-14 | Invibio Ltd | Polymer and articles |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006241363A (en) * | 2005-03-04 | 2006-09-14 | Ntn Corp | Porous item made of aromatic polyether ketone resin and its manufacturing method |
| WO2007051307A2 (en) * | 2005-11-04 | 2007-05-10 | Ppd Meditech | Porous material and method for fabricating same |
| WO2010077948A1 (en) * | 2008-12-30 | 2010-07-08 | Orthovita, Inc. | Bioactive composites of polymer and glass and method for making same |
| EP2338532A2 (en) * | 2009-12-23 | 2011-06-29 | Fundacion Inasmet | Porous PEEK article as an implant |
-
2011
- 2011-10-12 GB GBGB1117633.6A patent/GB201117633D0/en not_active Ceased
-
2012
- 2012-01-13 GB GB1200550.0A patent/GB2499778A/en not_active Withdrawn
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006241363A (en) * | 2005-03-04 | 2006-09-14 | Ntn Corp | Porous item made of aromatic polyether ketone resin and its manufacturing method |
| WO2007051307A2 (en) * | 2005-11-04 | 2007-05-10 | Ppd Meditech | Porous material and method for fabricating same |
| WO2010077948A1 (en) * | 2008-12-30 | 2010-07-08 | Orthovita, Inc. | Bioactive composites of polymer and glass and method for making same |
| EP2338532A2 (en) * | 2009-12-23 | 2011-06-29 | Fundacion Inasmet | Porous PEEK article as an implant |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2536388A (en) * | 2016-06-29 | 2016-09-14 | Invibio Ltd | Polymer and articles |
| GB2536388B (en) * | 2016-06-29 | 2017-05-10 | Invibio Ltd | Phosphate stabilised polyetheretherketone (PEEK) and use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| GB201200550D0 (en) | 2012-02-29 |
| GB201117633D0 (en) | 2011-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8829096B2 (en) | Polymeric materials | |
| EP2300516B1 (en) | Polymeric materials | |
| CA2739979A1 (en) | Polymeric materials | |
| Will et al. | Bioactive glass-based scaffolds for bone tissue engineering | |
| He et al. | Additive manufacturing of bioactive glass and its polymer composites as bone tissue engineering scaffolds: a review | |
| US20040023784A1 (en) | Bioactive biphasic ceramic compositions for artificial bone and method for making the same | |
| EP4210922B1 (en) | Method for forming an implantable medical device with varied composition and porosity | |
| Bretcanu et al. | Novel resorbable glass-ceramic scaffolds for hard tissue engineering: from the parent phosphate glass to its bone-like macroporous derivatives | |
| US20190210273A1 (en) | Bioactive Glass/Polymer Composite Filament, and Methods of Making | |
| Allaf et al. | Fabrication of co‐continuous poly (ε‐caprolactone)/polyglycolide blend scaffolds for tissue engineering | |
| GB2499778A (en) | Polymeric materials | |
| WO2011107803A1 (en) | Polymeric materials | |
| CN101050053B (en) | Method for preparing engineering material of bone tissue and application | |
| Mancuso | Processing and characterisation of novel bioceramics for load bearing applications | |
| WO2012098378A1 (en) | Polymeric materials | |
| Jones | Bioactive glass as synthetic bone grafts and scaffolds for tissue engineering | |
| Erasmus | Synthesis, testing and characterization of porous biocompatible porous bioactive glasses for clinical use | |
| Siekkinen | The impact of dissolution products and solution pH on in vitro behaviour of the bioactive glasses 45S5 and S53P4 | |
| Sinitsyna | In Vitro Dissolution of Bioactive Glasses with the Focus on S53P4-Derived Products | |
| Lalzawmliana et al. | Bioceramics System for Biomedical Application | |
| Corvaglia | Design and optimization of hybrid formulations based on PLLA and inorganic phases for 3D printing of bone scaffolds | |
| CN118453954A (en) | A 3D printed organic-inorganic composite scaffold with interconnected holes and its preparation method and application | |
| Jones | Hierarchical porous scaffolds for bone regeneration | |
| Ke | Porous tricalcium phosphate scaffold for bone tissue regeneration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |